Status:
RECRUITING
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Lead Sponsor:
Sherief Abd-Elsalam
Conditions:
Brain Injuries
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE3
Brief Summary
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Detailed Description
The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Eligibility Criteria
Inclusion
- Children with traumatic brain injury: Moderate and Severe.
Exclusion
- Underlying CNS disorders,
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04499755
Start Date
June 1 2020
End Date
December 10 2030
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt